InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| PMA - Phorbol myristate acetate | Revisiting the Gram-Negative Lipoprotein Paradigm. | 2015 | J Bacteriol. | LoVullo E.D. et al. | DOI: 10.1128/JB.02414-14 |
| PMA - Phorbol myristate acetate | Distinct pathways of humoral and cellular immunity induced with the mucosal a... | 2014 | J Immunol. | Bielinska A.U. et al. | DOI: 10.4049/jimmunol.1301424 |
| Blasticidin | A complex V ATP5A1 defect causes fatal neonatal mitochondrial encephalopathy. | 2013 | Brain | Jonckheere A.I. et al. | DOI: 10.1093/brain/awt086 |
| HKLM | Programmed cell death 1 inhibits inflammatory helper T-cell development throu... | 2013 | PNAS | Rui Y. et al. | DOI: 10.1073/pnas.1315828110 |
| Anti-mouse Dectin-1 (CLEC7A) antibody | Characterization and biological effects of two polysaccharides isolated from ... | 2015 | Carbohydr Polym. | Lee J.B. et al. | DOI: 10.1016/j.carbpol.2014.04.013 |
| 293/TLR4-MD2-CD14 | Yeast virus-derived stimulator of the innate immune system augments the effic... | 2014 | J Virol. | Claudepierre M.C. et al. | DOI: 10.1128/JVI.03819-13 |
| NF-κB and NLRP3 inflammasome inhibitor - BAY 11-7082 | Sensing of Bacterial Cyclic Dinucleotides by the Oxidoreductase RECON Promote... | 2017 | Immunity. | McFarland A.P. et al. | DOI: 10.1016/j.immuni.2017.02.014 |
| PRR Compound Screening and Profiling Service | Poly(Anhydride) Nanoparticles Act as Active Th1 Adjuvants through Toll-Like R... | 2011 | Clin.Vaccine Immunol. | Tamayo I. et al. | DOI: 10.1128/CVI.00164-10 |
| TLR4-based adjuvant - MPLA-SM VacciGrade™ | Systemic immunization with an epitope-based vaccine elicits a Th1-biased resp... | 2012 | Vaccine. | Li H.B. et al. | DOI: 10.1016/j.vaccine.2012.10.091 |
| Anti-HLA Class II Control | False Positive B-Cells Crossmatch after Prior Rituximab Exposure of the Kidne... | 2016 | Case Rep Transplant. | Desoutter J. et al. | DOI: 10.1155/2016/4534898 |
| Nigericin | Inflammasome-derived exosomes activate NF-κB signaling in macrophages | 2016 | J Proteome Res. | Zhang Y. et al. | DOI: 10.1021/acs.jproteome.6b00599 |
| pFUSE2-CLIg-mK | High-affinity, pan-specific monoclonal antibodies that target cysteinyl leuko... | 2017 | J Lipid Res. | King A.N. et al. | DOI: 10.1194/jlr.M075614 |
| Loxoribine | Different mechanisms of apolipoprotein E isoform-dependent modulation of pros... | 2015 | FASEB J. | Li X. et al. | DOI: 10.1096/fj.14-262683 |
| PlasmoTest™ - Mycoplasma Detection Kit | PI3Kδ activates E2F1 synthesis in response to mRNA translation stress. | 2017 | Nat Commun. | Gnanasundram S.V. et al. | DOI: 10.1038/s41467-017-02282-w |
| IL-33 Reporter HEK 293 Cells | Novel noncompetitive IL-1 receptor-biased ligand prevents infection- and infl... | 2015 | J Immunol. | Nadeau-Vallée M. et al. | DOI: 10.4049/jimmunol.1500758 |
| THP1-Blue™ ISG Cells | THP-1 cell line: An in vitro cell model for immune modulation approach. | 2014 | Int Immunopharmacol. | Chanput W. et al. | DOI: 10.1016/j.intimp.2014.08.002 |
| AddaVax™ | Carbohydrate fatty acid monosulphate esters are safe and effective adjuvants ... | 2017 | Vaccine. | Hilgers L.A. et al. | DOI: 10.1016/j.vaccine.2017.04.055 |
| 2'3'-cGAMP | DMXAA causes tumor site-specific vascular disruption in murine non-small cell... | 2014 | PLoS One. | Downey C.M. et al. | DOI: 10.1371/journal.pone.0099988 |
| pCpGfree-basic | Krüppel like factor 4 promoter undergoes active demethylation during monocyte... | 2014 | PLoS One. | Karpurapu M. et al. | DOI: 10.1371/journal.pone.0093362 |
| LumiKine™ Xpress mIFN-β 2.0 | SIDT2 Transports Extracellular dsRNA into the Cytoplasm for Innate Immune Rec... | 2017 | Immunity. | Nguyen TA. et al. | DOI: 10.1016/j.immuni.2017.08.007 |